Skip to main content
logo
Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
11.38
-0.04 (-0.35%)
Sep 18, 2026, 9:32 AM EDT - Market open

TNXP Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
29.113.1110.097.77--
Revenue Growth
196.02%29.85%29.94%---
Gross Profit
24.46.472.333.03--
Operating Income
-165.43-125.7-77.74-118.38-112.09-92.31
Net Income
-159.67-124.02-130.04-116.66-116.88-92.29
Earnings Per Share
-12.49-14.57-176.60---
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
176.23207.6498.7824.95120.23178.66
Total Debt
1.271.318.129.810.760.96
Net Cash (Debt)
174.96206.3390.6615.14119.47177.7
Net Cash Growth
40.15%127.59%498.99%-87.33%-32.77%134.57%
Net Cash Per Share
13.6824.24123.12---

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-152.99-99.84-60.93-102-98.05-75.56
Capital Expenditures
-5.12-3.37-0.12-7.9-48.15-35.31
Free Cash Flow
-158.11-103.21-61.05-109.9-146.2-110.86
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
83.83%49.34%23.07%38.97%--
Operating Margin
-568.43%-959.05%-770.20%-1523.94%--
Pretax Margin
-548.64%-946.22%-1288.25%-1501.78%--
Profit Margin
-548.64%-946.22%-1288.25%-1501.78%--
FCF Margin
-543.29%-787.47%-604.76%-1414.75%--

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
6.7314.776.113.04--